Eclipse SPV XXIX Files Exempt Offering Notice Under 3(c)(7)

Complexity: simple

Sentiment: neutral

Topics: private-placement, exempt-offering, fund-formation

TL;DR

**Eclipse SPV XXIX is raising private capital, not for public investors.**

AI Summary

Eclipse SPV XXIX, L.P. filed a Form D on March 24, 2026, indicating a notice of exempt offering of securities. This filing, under Section 3(c)(7) of the Investment Company Act, suggests that Eclipse SPV XXIX, L.P. is raising capital from qualified purchasers without registering with the SEC. For investors, this means the company is likely a private fund, and its investment opportunities are not available to the general public, which could limit future liquidity or direct investment options if one were considering this entity.

Why It Matters

This filing signals that Eclipse SPV XXIX, L.P. is a private investment vehicle, meaning its fundraising activities are not subject to the same public disclosure requirements as publicly traded companies.

Risk Assessment

Risk Level: low — This is a routine administrative filing for a private fund and does not indicate any immediate financial risk to public investors.

Analyst Insight

Investors should understand that this filing pertains to a private fund, meaning direct investment opportunities are likely restricted to qualified purchasers and not available to the general public. This filing does not impact publicly traded stocks.

Key Players & Entities

FAQ

What type of filing is this document?

This document is a Form D, which is a 'Notice of Exempt Offering of Securities' filed by Eclipse SPV XXIX, L.P. on March 24, 2026.

What specific section of the Investment Company Act is referenced in this filing?

The filing specifically references Item 3C.7, indicating it falls under Section 3(c)(7) of the Investment Company Act.

When was this filing accepted by the SEC?

The filing was accepted by the SEC on March 24, 2026, at 17:20:18.

What is the business address of Eclipse SPV XXIX, L.P.?

The business address for Eclipse SPV XXIX, L.P. is 514 HIGH STREET, SUITE 4, PALO ALTO, CA 94301.

What is the CIK number for Eclipse SPV XXIX, L.P.?

The CIK number for Eclipse SPV XXIX, L.P. is 0002098219.

Filing Stats: 1,177 words · 5 min read · ~4 pages · Grade level 16.7 · Accepted 2026-03-24 17:20:18

Key Financial Figures

Filing Documents

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   Eclipse SPV XXIX, L.P. Jurisdiction of Incorporation/Organization DELAWARE   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2025 Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   Eclipse SPV XXIX, L.P. Street Address 1 Street Address 2   514 HIGH STREET, SUITE 4     PALO ALTO   CALIFORNIA     94301   650-720-4667   3. Related Persons Last Name First Name Middle Name SUSAN LIOR Street Address 1 Street Address 2   514 HIGH STREET, SUITE 4       PALO ALTO   CALIFORNIA   94301   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Managing Member of the General Partner 4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes  No   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7)     7. Type of Filing   New Notice Date of First Sale       First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more than one year?   Yes   No     9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)       10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?   Yes   No Clarification of Response (if Necessary)       11. Minimum Investment Minimum investment accepted from any outside investor $   0 USD 12. Sales Compensation Recipient   Recipient CRD Number None     (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number  None     Street Address 1 Street Address 2             13. Offering and Sales Amounts   Total Offering Amount $ 50000000 USD Indefinite Total Amount Sold $ 0 USD Total Remaining to be Sold $ 50000000 USD Indefinite Clarification of Response (if Necessary)      14. Investors Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, Number of such non-accredited investors who already have invested in the offering       Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 0   15. Sales Commissions & Finders’ Fees Expenses Provide separately the amounts of sales commissions and fin

View Full Filing

View this D filing on SEC EDGAR

View on Read The Filing